Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 43Leukemia 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 37Leukemia, Myeloid, Acute 32Lymphoma 30Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma, Mantle-Cell 26Lymphoma, Follicular 26Leukemia, Myeloid, Chronic-Phase 26Lymphoma, Non-Hodgkin 25Leukemia, Myeloid, Accelerated Phase 24Lymphoma, B-Cell, Marginal Zone 23Lymphoma, Large B-Cell, Diffuse 22Hodgkin Disease 22Burkitt Lymphoma 22Anemia, Refractory, with Excess of Blasts 22Multiple Myeloma 21Congenital Abnormalities 19Myeloproliferative Disorders 18Lymphoma, Large-Cell, Immunoblastic 18Blast Crisis 18Dendritic Cell Sarcoma, Interdigitating 17Anemia, Refractory 16Recurrence 15Neoplasms, Plasma Cell 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Leukemia, Myelomonocytic, Chronic 13Leukemia, Biphenotypic, Acute 13Primary Myelofibrosis 12Myelodysplastic-Myeloproliferative Diseases 12

Interventions

Cyclophosphamide 45Prednisone 31N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 29Vincristine 28Doxorubicin 27Etoposide 22romidepsin 20Gemcitabine 18Lenalidomide 1610-propargyl-10-deazaaminopterin 16fludarabine phosphate 15Whole-Body Irradiation 15Peripheral Blood Stem Cell Transplantation 14Brentuximab Vedotin 14Azacitidine 13Mycophenolic Acid 12Dexamethasone 10Cyclosporine 10Bortezomib 10Alemtuzumab 10Rituximab 8fludarabine 7belinostat 7Methotrexate 6Cytarabine 6Busulfan 6Bendamustine Hydrochloride 6pembrolizumab 5denileukin diftitox 5Nivolumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell, Peripheral × Cord Blood Stem Cell Transplantation × Clear all
NCT01652014 2016-07-14

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Rutgers, The State University of New Jersey

Phase 2 Withdrawn
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡